ASPRUZYO SPRINKLE
These highlights do not include all the information needed to use ASPRUZYO SPRINKLE safely and effectively. See full prescribing information for ASPRUZYO SPRINKLE.ASPRUZYO SPRINKLE (ranolazine) extended-release granules, for oral useInitial U.S. Approval: 2006
dd9f81e4-50da-4551-aed5-559d304df42e
HUMAN PRESCRIPTION DRUG LABEL
Mar 2, 2022
SUN PHARMACEUTICAL INDUSTRIES, INC.
DUNS: 146974886
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Ranolazine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
Ranolazine
Product Details
FDA regulatory identification and product classification information